TCTR20180706001
Completed
Not Applicable
EUS-guided Radiofrequency Ablation of locally advanced Pancreatic cancer versus standard treatment (ERAP)
Faculty of Medicine King Chulalongkorn Memorial Hospital0 sites28 target enrollmentJuly 6, 2018
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- For unresectable solid pancreatic lesions
- Sponsor
- Faculty of Medicine King Chulalongkorn Memorial Hospital
- Enrollment
- 28
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Malignant Pancreatic Mass
- •2\. Size of Mass is not more than 50mm
- •3\. Concomitant chemotherapy wtihin 4 weeks
- •4\. Expected survival time longer than 3 months
Exclusion Criteria
- •1\. Undergoing radiotherapy
- •2\. ECOG score of more than 2
- •3\. Pregnancy
- •4\. On active heparin or anticoagulant therapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Endoscopic radiofrequency ablation combined with metal stent placement for malignant biliary obstruction in patients with surgically altered anatomyJPRN-UMIN000033957Aichi Medical University15
Completed
Phase 2
Phase II study: Radiofrequency ablation of locally advanced pancreatic cancercancer of the pancreasPancreatic cancer10015674NL-OMON37585niversitair Medisch Centrum Utrecht17
Recruiting
Not Applicable
Endobiliairy radiofrequency ablation for malignant biliairy obstruction, RACCOON-pilotParihilair cholangiocarcinomaNL-OMON27848Amsterdam UMC10
Completed
Not Applicable
Endoscopic radiofrequency ablation combined with bilateral metal stent placement for malignant hilar biliary obstructionresectable malignant hilar biliary obstructionJPRN-UMIN000033458Aichi Medical University40
Recruiting
Not Applicable
Endobiliary radiofrequency ablation for malignant biliary obstruction due to perihilar cholangiocarcinoma: a randomized controlled trialNL-OMON52313Amsterdam UMC73